سعر اف ام ال قطرة للعين 5 مل Fluorometholone 0.1% 2022

• Treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.Population: Adults and children aged 2 years and olderDailyMed (U.S. NLM)

• Elevation of intraocular pressure with possible glaucoma and infrequent optic nerve damage, posterior subcapsular cataract formation and delayed wound healing (in decreasing order of frequency).International label, same formulation · DailyMed (U.S. NLM)
• Secondary ocular infections (bacterial, fungal, viral); keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperaemia, loss of accommodation and ptosis have occasionally been reported; rarely acute anterior uveitis or globe perforation.International label, same formulation · DailyMed (U.S. NLM)

• Contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia and varicella, and in mycobacterial and fungal infections of the eye.International label, same formulation · DailyMed (U.S. NLM)
• Contraindicated in known or suspected hypersensitivity to any ingredient or to other corticosteroids.International label, same formulation · DailyMed (U.S. NLM)

• Prolonged use may increase intraocular pressure in susceptible individuals, resulting in glaucoma with optic nerve damage and visual acuity/field defects, and may cause posterior subcapsular cataract.International label, same formulation · DailyMed (U.S. NLM)
• Prolonged use may suppress the host immune response and increase the risk of secondary ocular infections; acute purulent eye infections may be masked or enhanced; fungal invasion should be suspected in persistent corneal ulceration.International label, same formulation · DailyMed (U.S. NLM)
• Topical corticosteroids can cause corneal and scleral thinning; use in the presence of thin corneal or scleral tissue may lead to perforation.International label, same formulation · DailyMed (U.S. NLM)

• Fluorometholone was embryocidal and teratogenic in rabbits at low multiples of the human ocular dose; there are no adequate and well-controlled studies in pregnant women; use in pregnancy only if the potential benefit justifies the potential risk to the fetus.International label, same formulation · DailyMed (U.S. NLM)
• It is not known whether topical ocular corticosteroids give detectable amounts in human milk; because of potential serious adverse reactions in nursing infants, decide whether to discontinue nursing or the drug.International label, same formulation · DailyMed (U.S. NLM)

English text not available for this section.